The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
Open accessAbstract
Although hormone therapy with antiandrogens has been widely used for the treatment of prostate cancer, some antiandrogens may act as androgen receptor (AR) agonists that may result in antiandrogen withdrawal syndrome. The molecular mechanism of this agonist response, however, remains unclear. Using mammalian two-hybrid assay, we report that antiandrogens, hydroxyflutamide, bicalutamide (casodex), cyproterone acetate, and RU58841, and other compounds such as genistein and RU486, can promote the interaction between AR and its coactivator, ARA70, in a dose-dependent manner. The chloramphenicol acetyltransferase assay further demonstrates that these antiandrogens and related compounds significantly enhance the AR transcriptional activity by cotransfection of AR and ARA70 in a 1:3 ratio into human prostate cancer DU145 cells. Our results suggest that the agonist activity of antiandrogens might occur with the proper interaction of AR and ARA70 in DU145 cells. These findings may provide a good model to develop better antiandrogens without agonist activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., & Goodman, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210702 · Cited by 1,464
Research works printed but not linked: 39
- 10.1126/science.3353726 · DOI · Paper page
- 10.1126/science.3283939 · DOI · Paper page
- 10.3322/canjclin.48.1.6 · DOI · Paper page
- C Huggins, C V Hodges Cancer Res 1, 293–297 (1941).
- 10.1002/pros.2990140204 · DOI · Paper page
- 10.1016/S0006-291X(05)80067-1 · DOI · Paper page
- 10.1074/jbc.270.34.19998 · DOI · Paper page
- 10.1074/jbc.270.46.27569 · DOI
- 10.1016/S0140-6736(05)61756-4 · DOI
- 10.1016/S0022-5347(17)36163-3 · DOI · Paper page
- 10.1200/JCO.1993.11.8.1566 · DOI · Paper page
- 10.1016/S0094-0143(05)70389-X · DOI
- 10.1007/BF00941991 · DOI
- 10.1016/S0090-4295(96)00558-4 · doi:10.1016/s0090-4295(96)00558-4
- 10.1002/1097-0142(19930201)71:3 <1046::AID-CNCR2820711424>3.0.CO;2-M · doi:10.1002/1097-0142(19930201)71:3
- F Neumann, G H Jacobi J Clin Oncol 1, 41–65 (1982).
- 10.1111/j.1365-2265.1994.tb02585.x · DOI
- 10.1159/000463971 · doi:10.1159/000463971
- H R Naik, J E Lehr, K J Pienta Anticancer Res 14, 2617–2620 (1994).
- 10.1002/pros.2990220408 · DOI · Paper page
- 10.1016/0022-4731(87)90159-2 · doi:10.1016/0022-4731(87)90159-2
- 10.1093/nar/19.6.1227 · DOI
- 10.1016/0960-0760(94)90250-X · doi:10.1016/0960-0760(94)90250-x
- 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S · DOI
- 10.1016/S0022-5347(17)37389-5 · DOI
- J P Gaddiopati, D G McLeod, H B Heidenberg, I A Sesterhenn, M J Finger, J W Moul, S Srivastava Cancer Res 54, 2861–2864 (1994).
- 10.1056/NEJM199505253322101 · DOI · Paper page
- 10.1073/pnas.93.11.5517 · DOI · Paper page
- A Mizokami, S-Y Yeh, C Chang Mol Endocrinol 8, 77–88 (1994).
- 10.1016/S0021-9258(18)41805-4 · DOI · Paper page
- 10.1016/0303-7207(94)90112-0 · DOI
- C Wang Ph.D. thesis (Univ. of Wisconsin-Madison, Madison, WI, 1997).
- A Mizokami, M Masai, J Shimazaki, A Sugita Nippon Hinyokika Gakkai Zasshi 83, 1801–1807 (1992).
- 10.1038/375377a0 · DOI · Paper page
- 10.1038/378681a0 · DOI · Paper page
- 10.1038/378690a0 · DOI · Paper page
- 10.1038/nsb0196-87 · DOI · Paper page
- J A Katzenellenbogen, B W O’Malley, B S Katzenellenbogen Mol Endocrinol 10, 119–131 (1996).
- M M Montano, V Muller, A Trobaugh, B S Katzenellenbogen Mol Endocrinol 9, 814–824 (1995).
Cited by
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Self-citationAndrogen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Self-citationInduction of apoptosis in breast cancer cells MDA-MB-231 by genistein
Li, Y., Upadhyay, S., Bhuiyan, M., & Sarkar, F. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202650 · Cited by 319
Metadata
- Authors
- Miyamoto, H., Yeh, S., Wilding, G., & Chang, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-06-23
- Volume
- 95
- Issue
- 13
- Pages
- 7379-7384
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2129750923
- Cited by
- 203
- References
- 1
- FWCI
- 18.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. https://app.cochat.ai/papers/10.1073/pnas.95.13.7379
- The paper
- Miyamoto, H., Yeh, S., Wilding, G., & Chang, C. (1998). Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.95.13.7379
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.